INCYTE GENOMICS INC
10-Q, EX-27, 2000-11-15
COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH
Previous: INCYTE GENOMICS INC, 10-Q, 2000-11-15
Next: DYNEGY INC /IL/, PRES14A, 2000-11-15



<TABLE> <S> <C>

<ARTICLE> 5

<S>                             <C>
<PERIOD-TYPE>                   9-MOS
<FISCAL-YEAR-END>                          DEC-31-2000
<PERIOD-END>                               SEP-30-2000
<CASH>                                         328,377
<SECURITIES>                                   316,255
<RECEIVABLES>                                   21,366
<ALLOWANCES>                                       351
<INVENTORY>                                          0
<CURRENT-ASSETS>                               684,574
<PP&E>                                         169,099
<DEPRECIATION>                                  72,814
<TOTAL-ASSETS>                                 865,924
<CURRENT-LIABILITIES>                           53,271
<BONDS>                                        203,167
                                0
                                          0
<COMMON>                                            64
<OTHER-SE>                                     609,422
<TOTAL-LIABILITY-AND-EQUITY>                   865,924
<SALES>                                              0
<TOTAL-REVENUES>                               138,751
<CGS>                                                0
<TOTAL-COSTS>                                        0
<OTHER-EXPENSES>                               138,621
<LOSS-PROVISION>                                     0
<INTEREST-EXPENSE>                               7,794
<INCOME-PRETAX>                               (22,365)
<INCOME-TAX>                                         0
<INCOME-CONTINUING>                                  0
<DISCONTINUED>                                       0
<EXTRAORDINARY>                                      0
<CHANGES>                                            0
<NET-INCOME>                                  (22,365)
<EPS-BASIC>                                   (0.36)
<EPS-DILUTED>                                   (0.36)


</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission